Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy.
Elia Lo PrioreDavid M LivermoreNiccolo BuettiPhilipp JentNiklas PelzerCarlo CasanovaHansjakob FurrerBaharak Babouee FluryPublished in: Open forum infectious diseases (2020)
We present a successful treatment, with tigecycline monotherapy, of acute prostatitis caused by multidrug-resistant Escherichia coli harboring an NDM-1 carbapemenase along with a CMY-2 cephalosporinase and a TEM ESBL.